Revyve Raises €24 Million to Advance Sustainable Egg-Replacing Yeast Proteins

Revyve Secures Groundbreaking Funding

On September 23, 2025, Revyve, a Dutch food-tech scale-up, announced a remarkable achievement in its growth journey by securing nearly €24 million in Series B financing. This pivotal round of funding increases the company’s total investment to more than €40 million, positioning it for a significant commercial rollout of its functional yeast proteins designed to replace eggs in various food products.

A Collective Effort from Diverse Investors

The Series B funding round witnessed participation from notable investors, including the ABN AMRO Sustainable Impact Fund and Invest-NL, alongside support from the Brabant Development Agency (BOM) and strategic investments from Lallemand Bio-Ingredients’ Swiss affiliate Danstar Ferment, along with Grey Silo Ventures. Existing backers, Oost NL and Royal Cosun, demonstrated their faith in Revyve by increasing their investments.

This funding originates from a well-rounded mix of institutional, public, and strategic investors, all committed to supporting Revyve's goal of reshaping the alternative protein landscape with next-generation clean-label solutions.

Addressing Key Industry Challenges

Revyve has made a name for itself in producing yeast proteins that effectively mimic the versatile functionalities of eggs in numerous food categories, including baked goods, sauces, alternative meats, and plant-based dairy products. Their innovative ingredients stand out due to their natural composition, sustainable sourcing, and price competitiveness, addressing three pressing industry challenges:

1. Rising Egg Prices: Increasing costs have raised the demand for affordable and stable alternatives.
2. Concerns Over Ultra-Processed Foods: Manufacturers are under growing pressure to eliminate undesirable additives while preserving food functionality.
3. Sustainability: There is a pronounced shift among retailers and food manufacturers to reduce carbon footprints throughout the supply chain.

Cedric Verstraeten, CEO of Revyve, highlighted the importance of replicating eggs' unique properties to maintain consumer texture preferences. “Food manufacturers are reducing their egg usage due to price hikes and sustainability targets, and it’s vital to replicate the functionality that consumers expect. Our yeast proteins offer an affordable and clean-label solution for egg substitution,” he explained.

Plans for Production Scaling

In 2024, Revyve will unveil its pioneering production plant in Dinteloord, marking a significant milestone in scaling their operations. The facility has already begun full-scale production, demonstrating the capability to manufacture and supply industrial volumes efficiently. With the fresh influx of funding, Revyve aims to enhance its output to exceed 1,600 tons per year, securing consistent supply for its global clients.

Verstraeten noted, “We have received tremendous local support to rapidly reach industrial-scale production. With a talented team and robust investment backing, we are now well-equipped for ambitious global expansions.”

Strong Confidence from Investors

The financial backing received in this latest round conveys the market's confidence in Revyve's proprietary technology and vast market potential. Hanna Zwietering, Senior Investment Manager at ABN AMRO Sustainable Impact Fund, expressed excitement stating, “Revyve is a pioneer in sustainable alternatives to traditional egg components. Their solution fills a vital gap in the food transition with scalable ingredients that also bear a low environmental impact.”

Lisette Kersting-van der Boog, Senior Investment Manager of Invest-NL, also praised Revyve’s role in driving global protein transformation and circular solutions that mitigate pressure on essential resources.

Future Prospects

With production already up and running, Revyve is currently serving clients across Europe, the UK, the USA, Canada, Mexico, and Australia. Building on this momentum, the company plans to present its latest innovations and partnerships at two major trade shows: Anuga in Cologne from October 4-8, 2025, and Food Ingredients Europe in Paris from December 2-4, 2025.

Conclusion

Revyve stands as a testament to the potential of innovation in food technology. With its commitment to developing sustainable food systems and creating products that enhance consumer experience while being environmentally conscious, Revyve is poised for significant growth. As it continues to advance its yeast protein solutions, the company reinforces its position as a leader in the alternative protein market.